Due to the days lost to the government shutdown, the Nuclear Regulatory Commission has extended the public comment period for a draft environmental impact statement for the TX-1 advanced nuclear fuel fabrication facility being built in Oak Ridge, Tenn.

Small modular reactor developer X-energy and its subsidiary TRISO-X announced yesterday the start of aboveground construction for its TX-1 advanced nuclear fuel fabrication facility in Oak Ridge, Tenn.  The first-in-the-nation facility will be the first of two Oak Ridge facilities built to manufacture the company’s TRISO fuel for use in its Xe-100 SMR.

The Department of Energy’s Office of Environmental Management has issued a request for offer (RFO) seeking proposals from U.S. companies to build and power AI data centers on the DOE’s Paducah Site in Kentucky. Companies are being sought to potentially enter into one or more long-term leasing agreements at the site that would be solely funded by the applicants.

The Smithsonian-affiliated American Museum of Science & Energy in Oak Ridge, Tenn., is partnering with the East Tennessee Economic Council (ETEC) to celebrate Nuclear Science Week from Monday, October 20, to Friday, October 24.

Hash Hashemian
president@ans.org

Last month, I talked about my goal of strengthening ANS’s voice, in part by attending three conferences. I have now checked the first event off that list: the Nuclear Opportunities Workshop.

This year, NOW took another step in outgrowing its “workshop” moniker and transitioning to a full-fledged regional conference and expo. What started only a few years ago as a small gathering in Oak Ridge, Tenn., with roughly 50 attendees has skyrocketed to an event with 1,100 people in attendance in Knoxville.

NOW’s popularity reflected how busy the roughly 350 nuclear companies in Tennessee have been in recent years. There is significant work going on surrounding Gen IV reactor development and deployment, advancements in new nuclear fuels, and defense-related builds like the Uranium Processing Facility.

ANS Executive Director/CEO Craig Piercy’s reflection on the 80th anniversary of the Trinity Test (Nuclear Newswire, July 16) was a thoughtful and fitting remembrance of the achievements and legacy of the World War II generation of nuclear pioneers. We also see legacy environmental cleanup as a vital next step as our industry launches what Secretary of Energy Chris Wright has defined as “Manhattan Project 2.0.”

Small modular reactor developer X-energy, together with its fuel-developing subsidiary TRISO-X, has selected Clark Construction Group to finish the building construction phase of its advanced nuclear fuel fabrication facility, known as TX-1, in Oak Ridge, Tenn. It will be the first of two Oak Ridge facilities built to manufacture the company’s TRISO fuel for use in its Xe-100 SMR. The initial deployment of the Xe-100 will be at Dow Chemical Company’s UCC Seadrift Operations manufacturing site on Texas’s Gulf Coast.

A reactor vessel has been installed by Kairos Power for its third Engineering Test Unit (ETU 3.0) at the company’s campus in Oak Ridge, Tenn.

The Nuclear Regulatory Commission has accepted for review the Tennessee Valley Authority’s construction permit application for a BWRX-300 small modular reactor at its Clinch River site in Tennessee. The NRC expects to complete its review by December 2026.

The Department of Energy’s Oak Ridge Office of Environmental Management recently completed the transfer of a 32-acre parcel at the East Tennessee Technology Park (ETTP) for private sector use. The transfer brings the total amount of property transferred from federal ownership for economic reuse to 1,832 acres at the ETTP, which was once home to the Oak Ridge Gaseous Diffusion Plant.

The Tennessee Valley Authority announced yesterday that it has submitted a construction permit application to the Nuclear Regulatory Commission for the construction of a GE Vernova Hitachi Nuclear Energy BWRX-300 small modular reactor at the Clinch River nuclear site in Oak Ridge, Tenn.

The U.S. Nuclear Regulatory Commission this week shared a portion of the construction permit application from the Tennessee Valley Authority to build a small modular reactor at the Clinch River nuclear site in Oak Ridge, Tenn.

In anticipation of TVA’s filing, NRC staff scheduled two public meetings in Oak Ridge for today, to discuss the agency’s process for licensing nuclear power plants.

The Department of Energy’s Office of Environmental Management said that crews with the Oak Ridge Office of Environmental Management (OREM) and its cleanup contractor UCOR are preparing to demolish another deteriorating Manhattan Project–era building at the Y-12 National Security Complex at Oak Ridge, Tenn.

The Department of Energy’s Office of Environmental Management has awarded a five-year contract worth up to $74.8 million to Independent Strategic Management Solutions for professional support services at the Oak Ridge Office of Environmental Management site in Oak Ridge, Tenn.

In a Q&A posted on TVA’s website last week about a “new nuclear heyday,” Bob Deacy shared his vision for the Clinch River nuclear site in Oak Ridge, Tenn.—and some news about next steps for the company’s small modular reactor plans.

The Tennessee Valley Authority’s senior vice president for the Clinch River project, Deacy described his vision for up to four SMRs built on plots smaller than a football field with state-of-the-art digital equipment and a newly trained workforce providing reliable 24/7 power to the grid.

Oak Ridge National Laboratory has successfully removed legacy radioactive waste stored for more than five decades, marking a significant cleanup milestone. The Oak Ridge Office of Environmental Management (OREM) and cleanup contractor UCOR processed and shipped highly radioactive source material, including radium-226 and boron, out of state for permanent disposal.

Nichols

The Oak Ridger has published the latest in a series of articles about General Kenneth D. Nichols, the Manhattan Project, and the 1954 Atomic Energy Act. The series has been produced by Nichols’ grandniece Barbara Rogers Scollin and Oak Ridge (Tenn.) city historian David Ray Smith. Gen. Nichols (1907–2000) was the district engineer for the Manhattan Engineer District during the Manhattan Project.

As Smith and Scollin explain, Nichols “had supervision of the research and development connected with, and the design, construction, and operation of, all plants required to produce plutonium-239 and uranium-235, including the construction of the towns of Oak Ridge, Tennessee, and Richland, Washington. The responsibility of his position was massive as he oversaw a workforce of both military and civilian personnel of approximately 125,000; his Oak Ridge office became the center of the wartime atomic energy’s activities.”

Diablo Canyon will host a commercial installation of the first on-site generative artificial intelligence deployment at a U.S. nuclear plant.

Pacific Gas & Electric is deploying Atomic Canyon’s Neutron Enterprise to assist the utility’s management of datasets associated with operations of Diablo Canyon. The software, which runs on Nvidia’s full-stack AI platform, enables intelligent document processing, computation of semantic embeddings, and generative capabilities. Its infrastructure allows nuclear facilities to process and analyze vast amounts of complex documentation with unprecedented speed and accuracy, according to the company.

Federal and contractor officials, community leaders, and educators gathered in Knoxville, Tenn., on October 29 for a roundtable event focused on ensuring the Oak Ridge Office of Environmental Management (OREM) and its partners have the resources and infrastructure needed to support a robust, talented workforce in the years ahead.

TerraPower Isotopes, a subsidiary of Bellevue, Wash.–based TerraPower, announced it is now producing actinium-225 at commercial scale, making the medical isotope available to the pharmaceutical industry through weekly production runs. As a result, TerraPower Isotopes said its actinium, after further manufacturing, is now used in multiple drug developers’ radiopharmaceuticals in human clinical trials across the globe.